Google Ads for Clinical Trials: Policy Requirements and Campaign Setup

Google blocks clinical trial recruitment ads in most of the world. If you operate in one of the 15 allowed countries, certification and campaign structure determine whether your ads run or get suspended before a single impression.

Graphed

Build AI Agents for Marketing

Build virtual employees that run your go to market. Connect your data sources, deploy autonomous agents, and grow your company.

Build Your First Agent

Where Google allows clinical trial recruitment ads

Google permits clinical trial recruitment advertising in exactly 15 countries: Australia, Belgium, Canada, China, France, Germany, Indonesia, Ireland, Israel, Italy, Netherlands, New Zealand, Spain, United Kingdom, and United States. Campaigns targeting any other country will be disapproved automatically, even if the advertiser holds valid certification.

Multi-country campaigns must exclude all non-allowed geographies at the campaign level. Google's system flags campaigns where location settings include both allowed and restricted countries, even if budget is allocated only to compliant regions. Create separate campaigns for each allowed country.

The allowed-country list does not change frequently, but Google does not announce updates. Verify the current policy page before every new campaign launch. Policy checks happen at ad approval, not just account certification.

Certification requirements and approval timeline

Advertisers must apply for and receive clinical trial recruitment certification before any ads can run, even in test mode. The certification form requires proof of ethics committee approval, sponsor or CRO details, and site location documentation. Incomplete applications extend review time or result in rejection.

Google's review process takes several business days, but can extend longer during high-volume periods. Plan for the longest timeline when setting recruitment campaign launch dates. Certification is account-level and applies to all campaigns within that Google Ads account, but does not transfer if you switch accounts. Moving campaigns to a new MCC or agency account requires re-certification from scratch.

One certification covers all studies as long as documentation is current. You do not need separate certifications for oncology versus cardiology trials. If ethics committee approval expires or trial sites change materially, update certification documentation immediately. Google conducts periodic re-reviews of certified accounts, and outdated documentation triggers suspension.

AI Agents for Marketing

Crash Course

Graphed

Free PDF · the crash course

AI Agents for Marketing Crash Course

Learn how to deploy AI marketing agents across your go-to-market — the best tools, prompts, and workflows to turn your data into autonomous execution without writing code.

Download the PDF

Campaign structure that clears policy review

Use Search campaigns as the primary format. Display and Video campaigns trigger more frequent manual reviews and higher disapproval rates because creative elements introduce more opportunities for policy interpretation. Search ads with text-only format pass automated review filters more reliably.

Campaign names and ad copy must avoid language that implies treatment efficacy, guarantees, or medical advice. "Join our diabetes study" passes review. "Cure your diabetes in our breakthrough trial" does not. The policy team flags words like "cure," "fix," "heal," and "eliminate" even in campaign names.

Landing pages must include clear disclosure of the study phase, sponsor name, and principal investigator contact information. Google's reviewers click through to landing pages during manual review. A landing page that omits sponsor details or uses vague language like "leading research institution" will trigger disapproval.

Exclude sensitive interest categories and audience signals that infer health conditions. Google's policy explicitly prohibits using audience segments like "diabetes interest" or "cancer diagnosis" for clinical trial campaigns. Stick to location radius and keyword match type to control reach.

Set location targeting to radius around trial sites, typically 10 to 50 miles depending on metro density. A campaign targeting all of California for a single San Diego trial site generates unqualified traffic from users who cannot realistically travel. Tighter radius targeting reduces wasted spend and improves pre-screener conversion rates.

Keyword strategy and search intent matching

High-intent keywords include condition name plus "clinical trial," "research study," "trial near me," and "study compensation." These phrases signal active interest in participation, not just information gathering. Users searching "diabetes clinical trial" are further down the funnel than those searching "what is diabetes."

Exact and phrase match types reduce wasted spend on informational queries that rarely convert to pre-screener submissions. Broad match in clinical trial campaigns triggers impressions on tangential searches that burn budget without producing qualified leads. A phrase match keyword like "[diabetes trial]" prevents your ad from showing on "diabetes lawsuit trial" or "diabetes trial results."

Add negative keywords for "lawyer," "lawsuit," "settlement," "cure," and "treatment success" to filter users seeking legal recourse or guarantees. A user searching "diabetes drug trial lawsuit" is researching legal claims, not volunteering for a study.

Keyword bids for clinical trial terms are often higher than standard healthcare CPCs because competition is concentrated among a small number of certified advertisers. Budget conservatively and expect cost per click to exceed general health content advertising.

Search volume for most condition-specific trial keywords is low, often under 500 monthly searches. Expect limited impression share even with strong bids. A campaign targeting "lupus clinical trial near me" in a mid-sized metro may generate only 50 to 100 impressions per week. Clinical trial search volume reflects the prevalence of people actively seeking studies, not the total disease population.

Graphed

Build AI Agents for Marketing

Build virtual employees that run your go to market. Connect your data sources, deploy autonomous agents, and grow your company.

Build Your First Agent

Ad copy and landing page compliance

Ad headlines must describe the study in plain language without implying benefit. "Diabetes Research Study Enrolling" passes review. "New Diabetes Treatment Study" does not, because "treatment" suggests therapeutic benefit rather than investigational research.

Do not use testimonials, patient imagery that suggests outcome, or language like "breakthrough," "revolutionary," or "cutting-edge" in ads or landing pages. These words trigger manual review flags and often result in disapproval. Stick to neutral descriptors: "research study," "investigational," "enrolling participants."

Landing pages must load quickly and be mobile-optimized. Google's policy enforcement includes page experience signals. Test landing page speed on mobile networks, not just office Wi-Fi, before launching campaigns.

Include a short pre-screener form on the landing page rather than requiring users to call or email. Five to eight questions is optimal. Form submissions convert better than call-only flows because users can submit information immediately. Collect only essential screening criteria: age, diagnosis status, treatment history, zip code. Longer forms reduce completion rates sharply.

IRB approval numbers and expiration dates should appear in the footer of the landing page, not in ad copy, to satisfy regulatory review without cluttering the ad. Google's reviewers look for this information on the landing page.

Budget planning and cost benchmarks

Cost per click for clinical trial keywords varies widely depending on condition prevalence and site competition in the metro area. Common conditions with multiple active trials in major metros push CPCs higher. Rare diseases in smaller geographies may see lower CPCs due to less competition, but total impression volume will be limited.

Cost per qualified pre-screener submission varies by condition and geography. A qualified submission means the user met basic inclusion criteria based on pre-screener responses, not just that they filled out the form. Track both raw form submissions and qualified submissions separately to calculate true cost per lead.

Daily budgets under $50 often fail to generate statistically significant data within a typical enrollment window of 8 to 12 weeks. At $5 CPC, a $50 daily budget produces 10 clicks per day. With a 10% form conversion rate, that is 7 form submissions per week. If only 30% of those are qualified, the campaign generates 2 qualified leads per week. That volume is too low to optimize bidding or creative effectively.

Front-load 60% of total budget in the first four weeks to capture early search interest when the study is new and fewer competing trials are active. Search volume for clinical trial keywords is finite. Users searching for trials today may enroll in a competitor's study next week. Early budget concentration maximizes visibility during the narrow window when qualified users are actively searching.

Track cost per randomized patient, not just cost per lead, by integrating CRM data with Google Ads offline conversion tracking. A campaign that generates cheap leads but low randomization rates is less valuable than one with higher cost per lead but better downstream conversion. Import randomization events back into Google Ads to optimize bidding toward enrollment, not just form fills.

AI Agents for Marketing

Crash Course

Graphed

Free PDF · the crash course

AI Agents for Marketing Crash Course

Learn how to deploy AI marketing agents across your go-to-market — the best tools, prompts, and workflows to turn your data into autonomous execution without writing code.

Download the PDF

Common disapproval reasons and fixes

Disapproval for "unapproved pharmaceutical or supplement" usually means ad copy or landing page implies the investigational product is an approved treatment. Rewrite to emphasize "research" and "investigational." Change "new diabetes medication" to "investigational diabetes treatment being studied."

Disapproval for "destination not accessible" occurs when the landing page is behind a login, loads slowly, or uses a redirect chain. Host landing pages on a fast, publicly accessible domain. Avoid URL shorteners or redirect services. Google's crawler must reach the final landing page in one hop without authentication.

If ads are disapproved for targeting a non-allowed country, check campaign location settings carefully. Google's geo-targeting can include users "interested in" a location even if they are physically elsewhere. Disable "People in, or who show interest in, your targeted locations" and select only "People in or regularly in your targeted locations."

Appeals take 1 to 2 business days. Include IRB approval and certification proof in the appeal form to expedite re-review. Attach the same ethics committee approval document submitted during initial certification, and reference the certification ID in the appeal text.

Reporting and attribution for enrollment outcomes

Google Ads conversion tracking must fire when a pre-screener is submitted, not when a user lands on the thank-you page, to avoid inflated counts from page refreshes. Place the conversion tag on form submission event, not page load. A thank-you page that reloads or that users bookmark and revisit will double-count conversions if the tag fires on page view.

Import offline conversion data into Google Ads to optimize bidding toward downstream outcomes, not just form fills. Offline conversions include qualified pre-screeners, scheduled visits, and randomized patients. Google's Smart Bidding algorithms use this data to prioritize clicks more likely to result in enrollment. Upload a CSV with click ID and conversion value, or use the API for automated imports.

Graphed connects clinical trial CRM data with ad spend and automates enrollment-per-dollar reporting without manual CSV uploads or Looker queries. Standard Google Ads reports show cost per click and cost per form submission. Connecting CRM enrollment data surfaces cost per randomized patient, time from click to randomization, and site-level performance without exporting data and joining tables in spreadsheets.

Compare cost per randomized patient across campaigns and geographies every two weeks to reallocate budget toward higher-yield sites. A site with lower cost per form submission but poor screen-in rates may deliver worse cost per randomization than a site with higher upfront lead costs but better qualification. Shift budget toward sites and campaigns that produce enrollment, not just activity.

Track time-to-fill by site using ad click timestamp and randomization date to identify whether paid acquisition is faster than investigator referrals. If paid traffic randomizes patients in 14 days while referral patients take 45 days, the higher cost per patient from ads may be justified by faster enrollment and earlier trial completion. Time-to-fill is a hidden cost variable that standard CPC and cost-per-lead reporting misses.

---

See Graphed in action.